Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV.
Laura LabateGiorgia BrucciGiulia CiccareseBianca BruzzoneValentina RicucciFederica StefanelliEmanuele DelfinoLucia TaramassoMatteo BassettiAntonio Di BiagioPublished in: International journal of STD & AIDS (2022)
Monkeypox (MPXV) usually causes a mild and self-limited infection. To date there are no data about cidofovir for the treatment for MPXV in humans. We report a case of a 25 years-old Brazilian man with a concurrent diagnosis of acute HIV (human immunodeficiency virus) infection, primary syphilis and MPXV infection with a nasal lesion successfully treated with intravenous cidofovir.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv positive
- hiv testing
- men who have sex with men
- hiv infected
- newly diagnosed
- hepatitis c virus
- hiv aids
- endothelial cells
- chronic rhinosinusitis
- liver failure
- respiratory failure
- electronic health record
- south africa
- drug induced
- induced pluripotent stem cells
- radiation therapy
- low dose
- intensive care unit
- artificial intelligence
- rectal cancer